PetMeds And Dutch Team Up For Veterinary Care And Prescriptions
PetMeds and Dutch are bringing telemedicine to pets. Courtesy of Dutch
PetMed Express Inc., the parent company of PetMeds and PetCareRx has entered a strategic partnership with virtual veterinary care provider Dutch to expand its provider ecosystem with affordable, accessible pet healthcare options. The new partnership will enable pet owners to leverage Dutch's technology and veterinary team to secure prescriptions for PetMeds' medications.
Pet owners, through the partnership, can sign up for a monthly Dutch membership,which will allow them to connect virtually for appointments, which are available 24/7, with veterinarians in 34 states. Since its launch four years ago, Dutch has completed almost 700,000 visits and offers treatment options for more than 150 conditions, including providing flea and tick medication and treatments for allergies and joint pain.
'Because they're technologically advanced, because they're able to cover the majority of the country and because they have over 200 veterinarians of their own made us feel very comfortable with them,' Sandra Campos, CEO of PedMeds, said of Dutch.
'Technology has evolved and in this case Dutch has proven that they continue to improve the technologies and are able to implement them within our own web site, which will make it much more seamless for the customer where they don't have to go and log onto a whole new platform,' Campos added.
Today, customers and pet owners can go to Dutch and get same-day care and talk to a veterinarian for less than $10 a month, less than the cost of a carton of eggs. The veterinarian is able to write a prescription, create a treatment plan and save consumers pain, time and money by getting them care right away.
'Dutch is a membership model,' said Joe Spector, founder and CEO. 'Think of it as Costco where you pay $120 for an annual membership and you get up to five pets covered, so up to five pets can be seen by the veterinarian at any time. We make money on the membership and the product partnership. In this case we would fulfill and make a margin on any products being purchased.'
Consumer awareness and adoption of veterinary telehealth options have been accelerating as pet owners look for more affordable and accessible ways to keep their pets healthy and happy. Dutch's recently released '2025 State of Veterinary Care Report' found that 129 million Americans, or roughly 38% of the population, live in vet-care 'deserts'—underscoring the need for more accessible pet care options.
Spector said the partnership could see tens of thousands of customers. There's almost 150 million pets in the U.S. and almost half get no care at all, according to Spector. 'We're talking about 75 million pets who could get help from a more affordable option,' he said.
'There's a lot of demand for pet telemedicine because it either can bring you peace of mind at the very least by speaking to a professional, not Dr. Google, and at the most, it saves you thousands of dollars of going to urgent care,' Spector said.
And the veterinarians in the Dutch network are seasoned and experienced. The average vet has over 15 years on the job. 'This isn't someone who couldn't find a job or just got out of school,' Spector said. 'This is someone who has been seeing pets for years and has decided to practice telemedicine. Veterinarians have come to believe they can provide better care when they see a pet in the comfort of their own home. We see a lot of anxious dogs. They're not better served in person and neither are cats because they become a different animal.'
Telehealth for people has continued to evolve and improve and grow as more consumers become accustomed to Zoom calls and telehealth. The same is true on the pet side where telehealth for peets is going to increase year-over-year and the popularity of pet insurance continues to grow, Campos said.
She added that PetMeds and Dutch wanted to provide a one-stop shop of solutions for pet owners whether they need a prescription and don't have access to a veterinarian or can't get to a vet or they need something after hours or on weekends. 'We give them that option without having to leave our site,' she said.
'We know that pets are better off when you're providing them with preventative solutions and you're taking care of their health,' Campos said. 'Rather than all of a sudden being hit with a disease or being hit with a critical condition, and then you have much greater costs as well, it's going to be much better to sustain their care and their maintenance over time.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
10 minutes ago
- Medscape
Peptide Predicts Cardiac Risk in Women With Unblocked Arteries
In women with angina pectoris but no obstructive coronary artery disease (ANOCA), a high concentration of pro-C-type natriuretic peptide (proCNP) is linked to a 73% increased risk for all-cause mortality. The substance also shows a positive association with atherosclerotic markers and a negative association with generalized inflammation. METHODOLOGY: The analysis focused on baseline associations between proCNP concentrations in plasma and clinical data in 1508 women with ANOCA, with exploratory analyses examining correlation patterns between proCNP and 185 cardiovascular plasma markers. Primary outcomes included all-cause death and a composite endpoint of cardiovascular events. Hazard ratios (HRs) were adjusted for age and creatine concentration, which have been linked to proCNP-derived peptides in plasma. TAKEAWAY: A high concentration of proCNP (≥ 53.4 pmol/L) was associated with a diagnosis of hypertension ( P = .001) and diabetes mellitus ( P < .001), postmenopausal status ( P < .001), but not age. = .001) and diabetes mellitus ( < .001), postmenopausal status ( < .001), but not age. The researchers identified 38 plasma markers significantly associated with proCNP, showing positive correlation with atherosclerotic markers and a negative correlation with pro-inflammatory markers. Women with high concentrations of proCNP were at increased risk for all-cause mortality (crude HR, 1.73; 95% CI, 1.10-2.73; P = .02) and adjusted HR, 1.57; 95% CI, 0.99-2.49; P = .06). = .02) and adjusted HR, 1.57; 95% CI, 0.99-2.49; = .06). No significant difference was found in rates of cardiovascular events between groups (crude HR, 1.08; 95% CI, 0.72-1.62; P = .71; and adjusted HR, 1.03; 95% CI, 0.68-1.56; P = .90). IN PRACTICE: 'The association between high proCNP concentrations and diabetes in women is notable as diabetes is associated with an excess risk of > 40% of fatal ischemic heart disease in women compared with men,' the researchers reported. 'Our findings thus raise the question whether increases in proCNP among elderly women are part of an adaptive vascular response to cardiovascular risk factors after menopause. Taken together, the baseline associations of the present study show high proCNP concentration in women with ANOCA is associated with a cardiovascular risk profile independent of NT-proBNP and low-grade inflammation.' SOURCE: This study was led by Peter D. Mark, MD, PhD, of the University of Copenhagen, in Copenhagen, Denmark. It appears online in the July 1 issue of JACC: ADVANCES . LIMITATIONS: As only women were examined in this study, it was impossible to evaluate whether the findings would be mirrored in men with ANOCA. Biomarkers, except for proCNP and high-sensitivity C-reactive protein, were quantified as relative plasma levels rather than absolute concentrations, limiting the interpretation of the statistical analyses. DISCLOSURES: This study received support through the Danish Biotek program via a grant from the Danish Health Ministry. The senior author, Jens P. Goetze, has served as a consultant for Novo Nordisk on biochemical method development.
Hamilton Spectator
10 minutes ago
- Hamilton Spectator
Man City signs Reijnders from AC Milan to complete $150M spending spree
Manchester City concluded a $150 million spending spree ahead of the Club World Cup by announcing the signing of Netherlands midfielder Tijjani Reijnders from AC Milan on Wednesday. The 26-year-old Reijnders moved for an initial fee of 55 million euros ($63 million) and is the second midfielder — after France playmaker Rayan Cherki — to join City in the special June 1-10 transfer window created to allow sides in the 32-team Club World Cup to reshape their squads. City paid Lyon $41 million for Cherki and also signed Algeria left back Rayan Aït-Nouri from Wolverhampton for $42 million. After deciding not to push to sign Florian Wirtz — the Germany playmaker is close to joining Liverpool, according to reports in the British media — City has spent around the same amount on three players. Add this latest splurge to an outlay of more than $200 million in the winter transfer window and City has already spent at least $350 million on players in 2025 to provide manager Pep Guardiola with a squad capable of reclaiming the Premier League title from Liverpool. Breakthrough season Reijnders has just been named as the best midfielder in Serie A after a breakthrough campaign in which he scored 15 goals and added five assists across all competitions for Milan, which endured a dismal season and failed to qualify for Europe. He joined Milan from AZ Alkmaar in 2023 for a fee of around 20 million euros (then $22.4 million) and recently signed a contract extension through to June 2030. That's the length of his contract at City, too. City is releasing De Bruyne to end his 10-year stint at the club and now has Reijnders and Cherki to link up with Rodri in an enticing midfield set-up. Reijnders said he was 'ecstatic' to be joining City. 'It is also a dream come true to play in the Premier League,' he said. 'This league has seen many of the best Dutch players perform through the years and it's an inspiration to follow in their footsteps.' City director of football Hugo Viana said Reijnders — who specializes in being a ball-carrying midfielder — will add 'extra energy, composure and creativity to our midfield.' City announced the transfer of Reijnders a day after the special transfer window closed but appears to have signed him in time for him to play in the new-look, 32-team Club World Cup, which starts on Saturday. City is in the same group as Juventus, Al Ain and Wydad Casablanca and its first match is on June 18. ___ AP soccer:
CNN
16 minutes ago
- CNN
Federal appeals court to hear arguments in Trump's long-shot effort to fight hush money conviction
Five months after President Donald Trump was sentenced without penalty in the New York hush money case, his attorneys will square off again with prosecutors Wednesday in one of the first major tests of the Supreme Court's landmark presidential immunity decision. Trump is relying heavily on the high court's divisive 6-3 immunity ruling from July in a long-shot bid to get his conviction reviewed – and ultimately overturned – by federal courts. After being convicted on 34 counts of falsifying business records, Trump in January became the first felon to ascend to the presidency in US history. Even after Trump was reelected and federal courts became flooded with litigation tied to his second term, the appeals in the hush money case have chugged forward in multiple courts. A three-judge panel of the 2nd US Circuit Court of Appeals – all named to the bench by Democratic presidents – will hear arguments Wednesday in one of those cases. Trump will be represented on Wednesday by Jeffrey Wall, a private lawyer and Supreme Court litigator who served as acting solicitor general during Trump's first administration. Many of the lawyers who served on Trump's defense team in the hush money case have since taken top jobs within the Justice Department. The case stems from the 2023 indictment announced by Manhattan District Attorney Alvin Bragg, a Democrat, who accused Trump of falsely categorizing payments he said were made to quash unflattering stories during the 2016 election. Trump was accused of falsifying a payment to his former lawyer, Michael Cohen, to cover up a $130,000 payment Cohen made to adult-film star Stormy Daniels to keep her from speaking out before the 2016 election about an alleged affair with Trump. (Trump has denied the affair.) Trump was ultimately convicted last year and was sentenced without penalty in January, days before he took office. The president is now attempting to move that case to federal court, where he is betting he'll have an easier shot at arguing that the Supreme Court's immunity decision in July will help him overturn the conviction. Trump's earlier attempts to move the case to federal court have been unsuccessful. US District Judge Alvin Hellerstein, nominated by President Bill Clinton, denied the request in September – keeping Trump's case in New York courts instead. The 2nd Circuit will now hear arguments on Trump's appeal of that decision on Wednesday. 'He's lost already several times in the state courts,' said David Shapiro, a former prosecutor and now a lecturer at John Jay College of Criminal Justice. And Trump's long-running battle with New York Judge Juan Merchan, Shapiro said, has 'just simmered up through the system' in New York courts in a way that may have convinced Trump that federal courts will be more receptive. Trump, who frequently complained about Merchan, has said he wants his case heard in an 'unbiased federal forum.' Trump's argument hangs largely on a technical but hotly debated section of the Supreme Court's immunity decision last year. Broadly, that decision granted former presidents 'at least presumptive' immunity for official acts and 'absolute immunity' when presidents were exercising their constitutional powers. State prosecutors say the hush money payments were a private matter – not official acts of the president – and so they are not covered by immunity. But the Supreme Court's decision also barred prosecutors from attempting to show a jury evidence concerning a president's official acts, even if they are pursuing alleged crimes involving that president's private conduct. Without that prohibition, the Supreme Court reasoned, a prosecutor could 'eviscerate the immunity' the court recognized by allowing a jury to second-guess a president's official acts. Trump is arguing that is exactly what Bragg did when he called White House officials such as former communications director Hope Hicks and former executive assistant Madeleine Westerhout to testify at his trial. Hicks had testified that Trump felt it would 'have been bad to have that story come out before the election,' which prosecutors later described as the 'nail' in the coffin of the president's defense. Trump's attorneys are also pointing to social media posts the president sent in 2018 denying the Daniels hush money scheme as official statements that should not have been used in the trial. State prosecutors 'introduced into evidence and asked the jury to scrutinize President Trump's official presidential acts,' Trump's attorneys told the appeals court in a filing last month. 'One month after trial, the Supreme Court unequivocally recognized an immunity prohibiting the use of such acts as evidence at any trial of a former president.' A White House spokesperson did not respond to a request for comment. If Trump's case is ultimately reviewed by federal courts, that would not change his state law conviction into a federal conviction. Trump would not be able to pardon himself just because a federal court reviews the case. Bragg's office countered that it's too late for federal courts to intervene. Federal officials facing prosecution in state courts may move their cases to federal court in many circumstances under a 19th century law designed to ensure states don't attempt to prosecute them for conduct performed 'under color' of a US office or agency. A federal government worker, for instance, might seek to have a case moved to federal court if they are sued after getting into a car accident while driving on the job. But in this case, Bragg's office argued, Trump has already been convicted and sentenced. That means, prosecutors said, there's really nothing left for federal courts to do. 'Because final judgment has been entered and the state criminal action has concluded, there is nothing to remove to federal district court,' prosecutors told the 2nd Circuit in January. Even if that's not true, they said, seeking testimony from a White House adviser about purely private acts doesn't conflict with the Supreme Court's ruling in last year's immunity case. Bragg's office has pointed to a Supreme Court ruling as well: the 5-4 decision in January that allowed Trump to be sentenced in the hush money case. The president raised many of the same concerns about evidence when he attempted to halt that sentencing before the inauguration. A majority of the Supreme Court balked at that argument in a single sentence that, effectively, said Trump could raise those concerns when he appeals his conviction. That appeal remains pending in state court. 'The alleged evidentiary violations at President-elect Trump's state-court trial,' the Supreme Court wrote, 'can be addressed in the ordinary course on appeal.'
